JP2025166032A5 - - Google Patents
Info
- Publication number
- JP2025166032A5 JP2025166032A5 JP2025129144A JP2025129144A JP2025166032A5 JP 2025166032 A5 JP2025166032 A5 JP 2025166032A5 JP 2025129144 A JP2025129144 A JP 2025129144A JP 2025129144 A JP2025129144 A JP 2025129144A JP 2025166032 A5 JP2025166032 A5 JP 2025166032A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- dose
- treatment
- spray
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762550656P | 2017-08-27 | 2017-08-27 | |
| US62/550,656 | 2017-08-27 | ||
| US201862664555P | 2018-04-30 | 2018-04-30 | |
| US62/664,555 | 2018-04-30 | ||
| PCT/US2018/046023 WO2019045989A1 (en) | 2017-08-27 | 2018-08-09 | METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF LYSINE SYNTHETIC ANALOGUES AND MIMETICS |
| JP2020532845A JP2020531586A (ja) | 2017-08-27 | 2018-08-09 | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 |
| JP2023088440A JP2023123440A (ja) | 2017-08-27 | 2023-05-30 | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023088440A Division JP2023123440A (ja) | 2017-08-27 | 2023-05-30 | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025166032A JP2025166032A (ja) | 2025-11-05 |
| JP2025166032A5 true JP2025166032A5 (cg-RX-API-DMAC7.html) | 2025-11-26 |
Family
ID=65525881
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532845A Withdrawn JP2020531586A (ja) | 2017-08-27 | 2018-08-09 | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 |
| JP2023088440A Withdrawn JP2023123440A (ja) | 2017-08-27 | 2023-05-30 | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 |
| JP2025129144A Pending JP2025166032A (ja) | 2017-08-27 | 2025-08-01 | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532845A Withdrawn JP2020531586A (ja) | 2017-08-27 | 2018-08-09 | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 |
| JP2023088440A Withdrawn JP2023123440A (ja) | 2017-08-27 | 2023-05-30 | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11413279B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4681713A2 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2020531586A (cg-RX-API-DMAC7.html) |
| KR (1) | KR102706114B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111315374A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2018324427B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020003735A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3073685A1 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2020002156A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019045989A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202001472B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220127227A (ko) * | 2019-10-29 | 2022-09-19 | 트라넥사믹 테크놀로지스, 엘엘씨 | 강화된 효능을 위한 합성 라이신 유사체, 유도체, 모방체 또는 프로드럭, 및 약제의 시너지 조합 |
| WO2021162879A1 (en) * | 2020-02-14 | 2021-08-19 | Tranexamic Technologies, Llc | Methods and compositions for antimicrobial use of synthetic lysine analogs, derivatives, mimetics, and prodrugs |
| JP7830159B2 (ja) * | 2021-02-26 | 2026-03-16 | ライオン株式会社 | コロナウイルスの細胞侵入抑制剤 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69524971T2 (de) * | 1994-10-28 | 2002-08-29 | Vitaleech Bioscience N.V., Rotterdam | Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen |
| WO2000037071A1 (en) * | 1998-12-21 | 2000-06-29 | Aps Kbus 8 Nr. 4788 | Topical treatment of skin disease |
| ES2156731B1 (es) * | 1999-05-31 | 2002-02-16 | Grifols Grupo Sa | Utilizacion del acido tranexamico para la preparacion de una composicion de fibrinogeno humano. |
| US7056947B2 (en) | 2002-07-05 | 2006-06-06 | Georgia Tech Research Corp. | Aza-peptide epoxides |
| AU2003272974A1 (en) | 2002-10-11 | 2004-05-04 | Daiichi Pharmaceutical Co., Ltd. | Anti-influenza virus agent |
| JP2008115168A (ja) * | 2006-10-12 | 2008-05-22 | Daiichi Sankyo Healthcare Co Ltd | 抗アデノウイルス剤 |
| JP5730211B2 (ja) * | 2008-11-20 | 2015-06-03 | バイオジェン アイデック エムエー インコーポレイティドＢｉｏｇｅｎ Ｉｄｅｃ Ｉｎｃ． | ウイルスのアルギニン不活化 |
| JP2010189301A (ja) * | 2009-02-17 | 2010-09-02 | Toshihito Eto | 新型インフルエンザ感染症に対する医薬組成物およびその利用 |
| US20120082677A1 (en) * | 2010-10-01 | 2012-04-05 | Sherif Salah Abdul Aziz | Compositions for the treatment of hcv and hbv |
| US20140271923A1 (en) * | 2013-03-14 | 2014-09-18 | Christopher Brian Reid | Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions |
| CN103405384B (zh) * | 2013-09-01 | 2015-05-13 | 吴静 | 氨甲环酸的药物组合物 |
-
2018
- 2018-08-09 KR KR1020207008860A patent/KR102706114B1/ko active Active
- 2018-08-09 BR BR112020003735-4A patent/BR112020003735A2/pt unknown
- 2018-08-09 AU AU2018324427A patent/AU2018324427B2/en not_active Ceased
- 2018-08-09 WO PCT/US2018/046023 patent/WO2019045989A1/en not_active Ceased
- 2018-08-09 CA CA3073685A patent/CA3073685A1/en active Pending
- 2018-08-09 CN CN201880070088.0A patent/CN111315374A/zh active Pending
- 2018-08-09 EP EP25197729.4A patent/EP4681713A2/en active Pending
- 2018-08-09 MX MX2020002156A patent/MX2020002156A/es unknown
- 2018-08-09 JP JP2020532845A patent/JP2020531586A/ja not_active Withdrawn
- 2018-08-09 US US16/610,504 patent/US11413279B2/en active Active
- 2018-08-09 EP EP18850491.4A patent/EP3672584A4/en not_active Withdrawn
-
2020
- 2020-02-26 MX MX2023009499A patent/MX2023009499A/es unknown
- 2020-03-09 ZA ZA2020/01472A patent/ZA202001472B/en unknown
-
2022
- 2022-05-25 US US17/824,602 patent/US20220288050A1/en not_active Abandoned
-
2023
- 2023-05-30 JP JP2023088440A patent/JP2023123440A/ja not_active Withdrawn
-
2024
- 2024-06-06 AU AU2024203839A patent/AU2024203839A1/en active Pending
-
2025
- 2025-08-01 JP JP2025129144A patent/JP2025166032A/ja active Pending
- 2025-09-11 US US19/326,649 patent/US20260007649A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025166032A5 (cg-RX-API-DMAC7.html) | ||
| JP2022551730A5 (cg-RX-API-DMAC7.html) | ||
| JP2010506952A5 (cg-RX-API-DMAC7.html) | ||
| CN113304166B (zh) | 核苷类化合物在制备治疗冠状病毒感染性疾病的药物中的用途 | |
| ATE526956T1 (de) | Viruzide zusammensetzungen | |
| CN102448438A (zh) | 抗流行性感冒调配物及方法 | |
| EA201000085A1 (ru) | dsPHK, ПРЕДНАЗНАЧЕННАЯ ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ИНФЕКЦИИ | |
| JP2011057709A5 (cg-RX-API-DMAC7.html) | ||
| JP2009256374A5 (cg-RX-API-DMAC7.html) | ||
| Zhang et al. | Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia | |
| JP2013520448A5 (cg-RX-API-DMAC7.html) | ||
| JP2022529343A5 (cg-RX-API-DMAC7.html) | ||
| JP2022534776A5 (cg-RX-API-DMAC7.html) | ||
| JP2022503733A5 (cg-RX-API-DMAC7.html) | ||
| JP2023522644A5 (cg-RX-API-DMAC7.html) | ||
| JP2020531586A5 (cg-RX-API-DMAC7.html) | ||
| JP2023520703A5 (cg-RX-API-DMAC7.html) | ||
| HRP20160891T1 (hr) | Farmaceutski sastav koji sadrži selenit ili spojeve koji sadrže selenit za liječenje cervikalne displazije ili karcinoma cerviksa | |
| RU2015112586A (ru) | Фармацевтические композиции, содержащие флурбипрофен | |
| JP2016510332A5 (cg-RX-API-DMAC7.html) | ||
| EA027291B1 (ru) | Способ лечения острого фарингита с помощью гидрохлорида амброксола | |
| RU2011148108A (ru) | Фармацевтическая композиция для профилактики и лечения инфекций p. aeruginosa, содержащая рекомбинантный лизоцим | |
| WO2022041634A1 (zh) | 一种预防病毒传染的复方制剂及其配制/使用方法与应用 | |
| RU2024133196A (ru) | Способы лечения гриппа и поксвирусных вирусных инфекций | |
| ES2531058T3 (es) | Composiciones farmacéuticas para terapia a corto plazo con glucocorticoides |